SELLAS Life Sciences Group, Inc.

Ownership Transactions Reported by 10 Insiders

Symbol
SLS on Nasdaq
Industry
Pharmaceutical Preparations
Location
7 Times Square, Suite 2503, New York, NY

There are no Buy or Sell transactions made by insiders since 2/1/2024

SELLAS Life Sciences Group, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Angelos M. Stergiou President and CEO, Director $971K Jan 10, 2025
Barbara A. Wood EVP, Gen. Counsel, Corp. Sec. $822K Jan 22, 2024
Dragan Cicic SVP, Chief Development Officer $350K Jan 10, 2025
John Burns Cfo $338K Jan 10, 2025
Robert Francomano Chief Commercial Officer $278K Jan 22, 2024
David A. Scheinberg Director $26.1K Jan 10, 2025
John Varian Director $25.9K Jan 10, 2025
Robert L. Van Nostrand Director $25.9K Jan 10, 2025
Jane Wasman Director $25.9K Jan 10, 2025
Katherine Bach Kalin Director $23.7K Jan 10, 2025

Recent Insider Transactions by Companies or Individuals for SELLAS Life Sciences Group, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.